How does a biotech balance great science with IP security to tell their story? Find out on today's episode of the Few & Far Between podcast!
Host Chris O'Brien welcomes Joshua Kresh, Emily Michiko Morris, and Mark Schultz from IPPI: The Intellectual Property Policy Institute. Tune in for a fascinating discussion on the dos and don'ts of IP protection.
Listen to the latest episode today!
On today's podcast, US Congressman Gus Bilirakis joins host Wayne Bowden to discuss the importance of rare disease awareness and treatment.
What makes India a smart and viable setting for today’s clinical trials? Join us for the latest episode of Few & Far Between. Biorasi's ...
"The history of rare disease drug development indicates that once you start looking harder for cases, you often tend to find them." - Will...